(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid

(2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid serves as a key chiral intermediate in synthesizing suzetrigine, a sodium channel blocker for neuropathic pain. This complex tetrahydrofuran carboxylic acid undergoes selective amidation and cyclization reactions to construct the essential stereospecific core structure, enabling precise development of targeted neurological therapeutics with enhanced binding specificity.

Synonyms: 2-Furancarboxylic acid, 3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-, (2R,3S,4S,5R)-;(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid;(2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl) tetrahydro-4,5-dimethyl -5-(trifluoromethyl)-2-furancarboxylic acid;free state:(2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furancarboxylic acid;VX548 Intermediates;Suzetrigine Impurity2;Suzetrigine8

Mol File: 2649470-87-9.mol